Safety is paramount for Neuralink. The technology, while promising, is still undergoing rigorous testing and development. Preclinical trials on animals and initial tests on humans aim to ensure biocompatibility and minimal adverse effects. It's essential to understand that before widespread commercial adoption, Neuralink will undergo a series of regulatory approvals, further ensuring its safety.